Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Yaogu Technology Development Co., Ltd. is a state-affiliated enterprise dedicated to the development and operation of the Wuhan National Bio-industry Base, commonly known as Biolake, in China. The company provides essential infrastructure, including specialized laboratory spaces and pilot production facilities, to support the life sciences and healthcare sectors. Beyond physical space, it offers public technical service platforms, investment facilitation, and incubation services for biotechnology and pharmaceutical companies. As a central pillar of the Wuhan biotech ecosystem, it facilitates technology transfer and industrial upgrading for regional healthcare enterprises. The company acts as a bridge between government policy and private sector innovation within the East Lake High-tech Development Zone.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 武汉药谷科技开发有限公司.